Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
, if applicable) or a letter from your university's Registrar office indicating you have fulfilled all doctoral program requirements and are eligible to graduate Why Join Us? This role provides an exceptional
-
We seek a talented and highly motivated computational postdoctoral fellow with a strong background in bioinformatics and passion in exploring the heterogeneity and evolution of tumor cells and the
-
Program . Job description The fellowships are aimed at early-career researchers with a basic science background or clinicians who aspire to a career in academia. We are particularly interested in candidates
-
Training Group (RTG) “Activation of anti-Microbial Effectors (ACME)” (coordinator: Dirk Schlüter, Hannover) funded by the German Research Foundation. The central aim of the program is to give highly
-
Postdoctoral Fellow – Mitochondrial Microproteins & Therapeutic Innovation Lena Ho Lab | Duke-NUS Medical School, Singapore Cardiovascular & Metabolic Disorders Programme Advance scientific
-
Fellowship Program supports outstanding early-career scientists and engineers from around the world. Fellows receive funding to pursue independent, cutting-edge research at KAUST for three years. Selection is
-
Scientist or Research Associate) will have great opportunities to collaborate with diverse groups of physicians, geneticists, and computational/experimental biologists, and get access the large-scale patient
-
programme designated to attract and empower the world’s brightest early-career researchers. This fellowship supports outstanding scientists who harness Artificial Intelligence (AI) to accelerate breakthroughs
-
, in all countries except Israel. Candidates currently enrolled in a PhD program may apply if they complete their dissertation defence successfully no later than June 1, 2026. Applicants must not have
-
August 2025 Background To create and contribute to the creation of knowledge by undertaking advanced analysis and validation experiments within the MRC BioFlare research programme: Although outcomes in RA